At the Bedside
- Initial priorities
- Assess airway, breathing, circulation immediately.
- Look for shock: tachycardia, hypotension, altered mental status, cool extremities, low urine output.
- Consider early airway protection if massive hematemesis, ongoing emesis, inability to protect airway, severe encephalopathy, or anticipated endoscopy in unstable patient.
- Focused history
- Hematemesis, coffee-ground emesis, melena, hematochezia with brisk bleed.
- Liver disease, alcohol use, known varices, prior GI bleed, peptic ulcer disease.
- NSAIDs, anticoagulants, antiplatelets, steroids.
- Symptoms of perforation or ischemia: severe pain, rigid abdomen.
- Exam
- Hemodynamic status, stigmata of cirrhosis, abdominal tenderness, rectal exam for melena/hematochezia.
- Signs of chronic anemia vs acute blood loss.
- Workup
- CBC, CMP, LFTs, PT/INR, type and screen/cross.
- BUN often elevated in UGIB.
- VBG/ABG and lactate if ill-appearing.
- ECG in older patients or those with chest pain/ischemia risk.
- Consider POCUS for volume status; it does not diagnose source but helps shock assessment.
- Resuscitation
- Two large-bore IVs or central access if needed.
- Crystalloid only as bridge; prioritize blood in significant hemorrhage.
- Transfuse PRBCs generally if Hgb <7 g/dL in most patients; consider higher threshold (often <8 g/dL) in active ischemia, significant CAD, or persistent shock.
- Massive transfusion protocol if unstable with ongoing large-volume bleeding.
- Source-directed treatment
- Nonvariceal suspected bleed: IV PPI.
- Variceal suspected bleed: octreotide + ceftriaxone + urgent GI.
- Reverse clinically significant coagulopathy when appropriate:
- Warfarin: 4-factor PCC + IV vitamin K.
- Dabigatran: idarucizumab if severe/life-threatening bleeding.
- Apixaban/rivaroxaban: andexanet alfa where available, or PCC per protocol.
- Platelet transfusion may be indicated in severe thrombocytopenia/ongoing hemorrhage; thresholds vary by scenario and procedure.
- Consults / definitive therapy
- GI for urgent endoscopy.
- ICU if unstable, ongoing transfusion need, variceal bleed, significant comorbidity.
- Interventional radiology or surgery if endoscopic control fails.
- Disposition decision points
- Admit most patients with confirmed/suspected significant UGIB.
- Very low-risk patients may be discharged only if hemodynamically stable, no ongoing bleeding, reassuring labs, low-risk score, and reliable follow-up.
Study Directive
- Memorize the immediate medication bundle for suspected variceal bleed: octreotide, ceftriaxone, blood, GI.
- Practice a 60-second UGIB resuscitation script: airway triggers, IV access, labs, transfusion threshold, reversal options.
- Draw a one-page comparison of variceal vs nonvariceal UGIB management from memory.
- Review anticoagulant reversal dosing in your institution’s formulary today.
- Do 10 board-style questions on GI bleed risk stratification and transfusion thresholds.
Recent Literature
- Review or guideline Endoscopic diagnosis and management of nonvariceal upper gastrointestinal hemorrhage (NVUGIH): European Society of Gastrointestinal Endoscopy (ESGE) Guideline - Update 2021
- Recent clinical EXPRESS: The Clinical Utility and Outcomes of Hemospray as Primary versus Salvage Therapeutic Modality for Endoscopic Hemostasis: A Retrospective Cohort Study